Multiomics Global Market Report 2024

Description

Multiomics refers to the integration and analysis of multiple omics data types, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, to gain a more comprehensive understanding of biological systems. This approach enhances comprehension of complex diseases, facilitates biomarker identification, and contributes to precision medicine initiatives.

The primary categories of multiomics are single-cell multiomics and bulk multiomics. Single-cell multiomics entails analyzing various biological molecules, such as DNA, RNA, proteins, and metabolites, within individual cells. It offers diverse platforms, such as genomics, transcriptomics, proteomics, metabolomics, and integrated omics platforms, for applications such as diagnostics, drug discovery and development, personalized medicine, agrigenomics, and others. These techniques are utilized by various end users, including academic and research institutions, pharmaceutical and biotechnology firms, clinical research organizations, and others.

The multiomics market research report is one of a series of new reports from The Business Research Company that provides multiomics market statistics, including the multiomics industry global market size, regional shares, competitors with multiomics market share, detailed multiomics market segments, market trends, and opportunities, and any further data you may need to thrive in the multiomics industry. These multiomics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The multiomics market size has grown rapidly in recent years. It will grow from $2.78 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 17.7%. The growth during the historic period can be attributed to increased biomedical research, augmented government and private funding, a surge in the prevalence of chronic diseases, technological advancements, and improved computational tools and software for data analysis.

The multiomics market size is expected to see rapid growth in the next few years. It will grow to $6.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to advances in artificial intelligence and machine learning, the expansion of clinical applications, the growing biopharmaceutical industry, the emergence of integrated multiomics platforms, and increasing use in agricultural and environmental research. Major trends expected during the forecast period include technological advancements, the launch of new commercial multiomics platforms, the adoption of spatially resolved multiomics analysis, increased adoption in biopharmaceutical research and development, and expansion into clinical diagnostics.

The increasing demand for personalized medicine is poised to propel the growth of the multiomics market. Personalized medicine, which tailors healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors, is gaining traction due to advancements in technology, a growing need for targeted therapies, and improvements in global healthcare. Multiomics plays a crucial role in personalized medicine by offering a comprehensive understanding of an individual's genetic, molecular, and metabolic profile, empowering healthcare providers to customize treatments according to each patient's unique characteristics. For instance, in February 2024, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022, as reported by the Personalized Medicine Coalition, a US-based non-profit organization. Thus, the increasing demand for personalized medicine is fueling the expansion of the multiomics market.

Leading companies in the multiomics market are focusing on developing advanced single-cell multiomics platforms to facilitate large-scale studies without compromising sample integrity. Single-cell multiomics platforms integrate various omics with artificial intelligence capabilities, enabling users to analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For example, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, introduced the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This cutting-edge system allows scientists to isolate, barcode, and analyze single cells with high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures minimal sample loss and offers flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, thereby enhancing researchers' ability to gain insights efficiently.

In October 2022, Clinical Microbiomics, a Denmark-based biotechnology company, acquired MS-Omics for an undisclosed amount. This strategic acquisition bolsters Clinical Microbiomics' leadership in the microbiome field and significantly enhances its capabilities in analyzing and understanding the intricate interactions within the microbiome. The acquisition enables Clinical Microbiomics to provide a comprehensive suite of multi-omics solutions tailored to the microbiome, offering valuable insights into its role in human health and disease. MS-Omics, based in Denmark, specializes in multiomics, including metabolomics.

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the multiomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The multiomics market consists of revenues earned by entities by providing services such as experimental design, sample preparation, data analysis, and data generation. The market value includes the value of related goods sold by the service provider or included within the service offering. The multiomics market also includes sales of instruments, consumables and reagents, microarrays, bioinformatics workstations and servers, and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiomics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Single-Cell Multiomics; Bulk Multiomics
2) By Platform: Genomics; Transcriptomics; Proteomics; Metabolomics; Integrated Omics Platforms
3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; AgriGenomics; Other Applications
4) By End User: Academics And Research Organization; Pharmaceutical And Biotechnology Companies; Clinical research Organization; Other End-Users
Companies Mentioned: Bayer AG; Thermo Fisher Scientific Inc.; Novartis AG; Becton Dickinson and Company; Eurofins Scientific SE
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18417

1. Executive Summary

2. Multiomics Market Characteristics

3. Multiomics Market Trends And Strategies

4. Multiomics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Multiomics Market Size and Growth

5.1. Global Multiomics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Multiomics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Multiomics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Multiomics Market Segmentation

6.1. Global Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Single-Cell Multiomics
Bulk Multiomics
6.2. Global Multiomics Market, Segmentation By Platform, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms
6.3. Global Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diagnostics
Drug Discovery And Development
Personalized Medicine
AgriGenomics
Other Applications
6.4. Global Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Academics And Research Organization
Pharmaceutical And Biotechnology Companies
Clinical research Organization
Other End-Users

7. Multiomics Market Regional And Country Analysis

7.1. Global Multiomics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Multiomics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Multiomics Market

8.1. Asia-Pacific Multiomics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Multiomics Market

9.1. China Multiomics Market Overview
9.2. China Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Multiomics Market

10.1. India Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Multiomics Market

11.1. Japan Multiomics Market Overview
11.2. Japan Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Multiomics Market

12.1. Australia Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Multiomics Market

13.1. Indonesia Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Multiomics Market

14.1. South Korea Multiomics Market Overview
14.2. South Korea Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Multiomics Market

15.1. Western Europe Multiomics Market Overview
15.2. Western Europe Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Multiomics Market

16.1. UK Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Multiomics Market

17.1. Germany Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Multiomics Market

18.1. France Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Multiomics Market

19.1. Italy Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Multiomics Market

20.1. Spain Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Multiomics Market

21.1. Eastern Europe Multiomics Market Overview
21.2. Eastern Europe Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Multiomics Market

22.1. Russia Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Multiomics Market

23.1. North America Multiomics Market Overview
23.2. North America Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Multiomics Market

24.1. USA Multiomics Market Overview
24.2. USA Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Multiomics Market

25.1. Canada Multiomics Market Overview
25.2. Canada Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Multiomics Market

26.1. South America Multiomics Market Overview
26.2. South America Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Multiomics Market

27.1. Brazil Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Multiomics Market

28.1. Middle East Multiomics Market Overview
28.2. Middle East Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Multiomics Market

29.1. Africa Multiomics Market Overview
29.2. Africa Multiomics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Multiomics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Multiomics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Multiomics Market Competitive Landscape And Company Profiles

30.1. Multiomics Market Competitive Landscape
30.2. Multiomics Market Company Profiles
- 30.2.1. Bayer AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Becton Dickinson and Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eurofins Scientific SE
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Multiomics Market Other Major And Innovative Companies

31.1. Agilent Technologies Inc.
31.2. Illumina Inc.
31.3. Shimadzu Corporation
31.4. Bruker Corporation
31.5. Bio-Techne
31.6. Azenta Life Sciences
31.7. 10x Genomics
31.8. Ginkgo Bioworks
31.9. Abcam limited
31.10. BioLegend
31.11. Oxford Nanopore Technologies Plc
31.12. Adaptive Biotechnologies
31.13. Pacific Biosciences
31.14. Standard BioTools
31.15. Parse Biosciences

32. Global Multiomics Market Competitive Benchmarking

33. Global Multiomics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Multiomics Market

35. Multiomics Market Future Outlook and Potential Analysis

35.1 Multiomics Market In 2028 - Countries Offering Most New Opportunities
35.2 Multiomics Market In 2028 - Segments Offering Most New Opportunities
35.3 Multiomics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer